Breast cancerLiver cancerPancreatic cancerProstate cancer
Established
1953
Beds
4,000+
Annual Volume
90,000+
Beijing
Home to top teams incl. Prof. Jiang Ze-Fei; national leader in precision breast oncology and minimally invasive intervention.
About the Hospital
The Chinese PLA General Hospital (301 Hospital) is a large modern general hospital integrating care, health services, teaching and research; its oncology departments are highly capable in minimally invasive hepatobiliary-pancreatic surgery, interventional oncology and robotic surgery.
The hospital operates a complete high-end equipment spectrum — da Vinci robots, CyberKnife, TOMO — and maintains a rigorous quality-control system refined through high-level care missions.
Hospital Strengths
01National leader in robotic surgery
Robotic hepatobiliary-pancreatic and urologic surgery volumes and complexity rank among the highest nationally, with several nationally pioneering procedures.
02A highland for interventional oncology
A complete interventional toolkit — TACE, ablation, radioactive seed implantation — with extensive experience in intermediate-advanced liver cancer.
03Rigorous quality and safety system
The military-hospital quality tradition ensures rigorous perioperative management, with excellent safety data for elderly and high-risk surgical patients.
02Interventional and comprehensive liver cancer care (TACE/ablation)
03Robotic urologic oncology surgery
04Surgery for elderly and high-risk cancer patients
Officially Reported Treatment Milestones
Nationally leading scale of robotic minimally invasive cancer surgery
2014–
Robotic surgery volume in urology and other specialties has long ranked among the world’s highest, with a scaled robotic minimally invasive system and national training programs.
Comprehensive cancer care at the national clinical research center for geriatric diseases
2016–
Relying on the national clinical research center for geriatric diseases, it built a perioperative evaluation and comprehensive care system for elderly cancer patients with complex comorbidities.